RNLX

Renalytix Plc RNLX

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode RNLX MSPR STRM ELEV ELUT CYTH MTVA MEIP CFMS IVC
6M -69.98 % -99.20 % 74.29 % -39.91 % -69.10 % -3.28 % 31.73 % 63.30 % 40.99 % -30.31 %
YTD -51.27 % -99.57 % 45.72 % -38.67 % -83.55 % 20.10 % -57.60 % 20.39 % -30.37 % 34.65 %
1Y -80.09 % -99.50 % -26.24 % -54.38 % -86.53 % -44.14 % -50.58 % 13.70 % -56.18 % -67.01 %
3Y -99.09 % -99.55 % -77.35 % -70.80 % -86.56 % -75.98 % -64.64 % -59.61 % -88.62 % -91.71 %
5Y -98.47 % -99.55 % -78.05 % -96.81 % -95.64 % -95.76 % -64.64 % -95.06 % -90.92 % -96.18 %
10Y -98.47 % -99.55 % -87.61 % -96.81 % -96.14 % -98.80 % -64.64 % -90.92 % -99.39 % -95.45 %
From the beginning -98.47 % -99.55 % -97.69 % -96.81 % -96.14 % -99.39 % -64.64 % -99.97 % -99.39 % -76.01 %

Dividend

MEI Pharma, Inc.

Invacare Corporation